MedTrace Logo

High Flow Therapy in ICUs Across Ibero America

NCT03364946 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 255

Last updated 2019-08-12

No results posted yet for this study

Summary

The study aims to describe the use of Nasal High Flow (NHF) in the intensive care units of participating centers in Iberoamerica. It will describe the indications for the use, the clinical outcome of patients , and the therapeutic failure of NHF therapy in patients staying in an intensive care unit in the participant centers in Iberoamerica.

Conditions

  • Nasal High Flow Therapy
  • Intensive Care Unit
  • Ventilatory Failure
  • Hypoxia
  • Hypercapnic Respiratory Failure

Interventions

OTHER

No intervention

No intervention, observational study

Sponsors & Collaborators

  • Fundación Santa Fe de Bogota

    lead OTHER

Principal Investigators

  • Leopoldo E Ferrer, MD · Fundación Santa Fe de Bogotá

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2019-08-01
Completion
2019-12-15

Countries

  • Colombia
  • Dominican Republic
  • Mexico
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03364946 on ClinicalTrials.gov